Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2012
11/29/2012CA2836800A1 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/29/2012CA2836649A1 Anti-cgrp compositions and use thereof
11/29/2012CA2836494A1 Individualized vaccines for cancer
11/29/2012CA2835755A1 Family of aryl, heteroaryl, o-aryl and o-heteroaryl carbasugars
11/29/2012CA2835147A1 Compositions and methods for efficacious and safe delivery of sirna using specific chitosan-based nanocomplexes
11/29/2012CA2834806A1 Drug delivery agents comprising cyclodextrin covalently linked to a gemini surfactant, and pharmaceutical compositions comprising the same
11/29/2012CA2834584A1 Fgfr-fc fusion protein and use thereof
11/29/2012CA2833203A1 Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
11/29/2012CA2833192A1 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
11/29/2012CA2832605A1 Pyridine-and pyrazine derivatives
11/29/2012CA2831966A1 Thiazole derivatives
11/29/2012CA2831161A1 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof
11/29/2012CA2828561A1 Activation of human t-helper/inducer cell, t-cytotoxic/suppressor cell, b-cell, and natural killer (nk)-cells and induction of natural killer cell activity against k562 chronic myeloid leukemia cells with modified citrus pectin
11/29/2012CA2827708A1 Solid forms of a pharmaceutically active substance
11/29/2012CA2827648A1 Tricyclic inhibitors of kinases
11/28/2012EP2527501A1 Polymorphisms predictive of anthracycline-induced cardiotoxicity
11/28/2012EP2527444A2 Antisense oligonucleotide modulation of stat3 expression
11/28/2012EP2527440A1 Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia
11/28/2012EP2527437A1 Novel anti-CD98 antibody
11/28/2012EP2527355A2 Polymorphic and amorphous salt forms of squalamine dilactate
11/28/2012EP2527344A1 Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
11/28/2012EP2527330A1 Inhibitors of the hedgehog pathway
11/28/2012EP2527326A1 Novel compounds having 4-pyridylalkylthio group as substituent
11/28/2012EP2527315A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
11/28/2012EP2527008A2 Anticancerous polymeric agents
11/28/2012EP2526967A1 Engineered anti-alpha v-integrin hybrid antibodies
11/28/2012EP2526946A1 Methods Using 3-(4-Amino-1-Oxo-1,3-Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione For Treatment Of Certain Leukemias
11/28/2012EP2526935A1 Hydrazidomycins
11/28/2012EP2526934A2 Inhibitors of bruton's tyrosine kinase
11/28/2012EP2526933A2 Inhibitors of bruton's tyrosine kinase
11/28/2012EP2526771A1 Inhibitors of bruton's tyrosine kinase
11/28/2012EP2526111A2 Aloe-emodin derivatives and use thereof for the treatment of cancer
11/28/2012EP2526102A1 Inhibitors of pi3 kinase
11/28/2012EP2526101A1 Crystalline forms of a purine derivative
11/28/2012EP2526093A2 Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
11/28/2012EP2525835A2 Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery
11/28/2012EP2525820A1 Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r)
11/28/2012EP2525799A2 (20s,22e)-2-methylene-19-nor-22-ene-1alpha,25-dihydroxyvitamin d3 analogs
11/28/2012EP2525796A2 Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
11/28/2012EP2525780A2 Synthetic nanostructures including nucleic acids and/or other entities
11/28/2012EP2525657A1 Composition for perinatal and neonatal stroke
11/28/2012CN1997394B Compositions and methods comprising an EGFL7 antagonist for modulating vascular development
11/28/2012CN1738829B New 2',5'-oligoadenylic acid analog
11/28/2012CN102803511A Materials and methods useful for affecting tumor cell growth, migration and invasion
11/28/2012CN102803487A Cancer antigen helper peptide
11/28/2012CN102803294A Anti-ASCT2 (system ASC amino acid transporter type 2) antibody
11/28/2012CN102803293A SIGLEC 15 antibodies in treating bone loss-related disease
11/28/2012CN102803279A Process for preparation of 1,2-diamino-cyclohexane-platinum (ii) complexes
11/28/2012CN102803264A 3-substituted-8-substituted-3h imidazo[5,1-d][1,2,3,5-tetrazin-4-one compounds and their use
11/28/2012CN102803259A 1H-Imidazo[4, 5-c]quinolinone compounds, useful for the treatment of proliferative diseases
11/28/2012CN102803250A 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP 17
11/28/2012CN102803246A HEDGEHOG pathway antagonists and therapeutic applications thereof
11/28/2012CN102803232A Antifungal 1, 2, 4-triazolyl Derivatives Having A 5- Sulfur Substituent
11/28/2012CN102803231A Antifungal 1,2,4-triazolyl derivatives
11/28/2012CN102803230A Antifungal 1,2,4-triazolyl derivatives having a 5-sulfur substituent
11/28/2012CN102803228A Acid-labile trigger units
11/28/2012CN102803227A Morpholinylquinazolines
11/28/2012CN102803225A Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/28/2012CN102802729A Liquid dosage forms of isotretinoin
11/28/2012CN102802658A Methods and compositions related to reduced met phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells
11/28/2012CN102802654A Vaccine therapy for choroidal neovascularization
11/28/2012CN102802616A Polyarginine Nanocapsules
11/28/2012CN102796709A Liver cancer-specific gene-virus and application thereof
11/28/2012CN102796254A Pegylated celastrol and preparation method and application thereof
11/28/2012CN102796235A Copolymer based on environmental response and preparation method thereof
11/28/2012CN102796224A Multifunctional bionic polymer, its preparation method and application
11/28/2012CN102796199A Fusion protein mutant of anti-cluster of differetiation (CD3) antibody Fv segment and interleukin 3, method for preparing fusion protein mutant and application of fusion protein mutant
11/28/2012CN102796198A Fusion protein of anti-cluster of differetiation (CD3) antibody Fv segment and interleukin 3, method for preparing fusion protein and application of fusion protein
11/28/2012CN102796180A Specific basic fibroblast growth factor (bFGF) binding peptide
11/28/2012CN102796179A Template - fixed peptidomimetics with antimicrobial activity
11/28/2012CN102796161A Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
11/28/2012CN102796160A 17ss-hsd1 and sts inhibitors
11/28/2012CN102796153A Novel antitumor component Swertiridoid A in swertia phragmitiphylla
11/28/2012CN102796144A Thomsen-Friedenreich (TF) antigen and TF antigen analogue and their chemoenzymatic synthesis method and use
11/28/2012CN102796140A Phosphate-containing isoxazoline derivatives and their preparation method and use
11/28/2012CN102796124A Di-beta-carboline alkali compound and preparation method, medicinal composition and application thereof
11/28/2012CN102796113A Xanthone compound, and preparation method and application thereof
11/28/2012CN102796110A Aniline pyrimidine compound and preparation method and application thereof
11/28/2012CN102796109A 4-aminoquinazoline compound and preparation method and application thereof
11/28/2012CN102796103A 6-(aryl formyl) imidazo [1,2-a] pyrimidine and 6-(aryl formyl) [1,2,4] triazol [4,3-a] pyrimidine serving as Hedgehog inhibitors and application thereof
11/28/2012CN102796099A Imidazoquinolines as lipid kinase inhibitors
11/28/2012CN102796097A Phenanthroindolizidine alkaloid derivative, and preparation method, medical composition and application thereof
11/28/2012CN102796081A Pyrimidine sulphonamide derivatives as chemokine receptor modulators
11/28/2012CN102796079A Method for preparing flumatinib mesylate
11/28/2012CN102796075A Benzocycloheptenes derivative as well as preparation method and medical application thereof
11/28/2012CN102796072A Alizarin dioxane derivatives, and preparation method and application thereof
11/28/2012CN102796066A Flavone compound and preparation method and application thereof
11/28/2012CN102796050A Cdc42 inhibitor and application thereof
11/28/2012CN102796017A Natural product deoxybostrycin derivatives and preparation method and application thereof
11/28/2012CN102795975A Saucernetin structure simplifier and preparation method, medicinal composition and application thereof
11/28/2012CN102793930A Novel bifunctional triphosphate-small interfering ribonucleic acid (3p-siRNA) for inhibiting proliferation of tumor cells and application of novel bifunctional 3p-siRNA
11/28/2012CN102793922A Method for treating neoplastic disease in body of mammals
11/28/2012CN102793914A Novel vascular endothelial cell vaccine and preparation method thereof
11/28/2012CN102793913A Tumor vaccine of recombinant murine EPS8 gene, and preparation method and application thereof
11/28/2012CN102793912A Dendritic cell (DC) tumor vaccine and preparation method thereof
11/28/2012CN102793900A Antitumor nutritional support medicine composition and preparation method thereof
11/28/2012CN102793847A Non-sulfured processing method of polygonatum
11/28/2012CN102793837A Healthcare product assisting in treating neoplastic diseases
11/28/2012CN102793835A Chinese herbal medicine formula and preparation method thereof
11/28/2012CN102793796A Codonopsis pilosula and astragalus anticancer decoction
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 2211